RECRUITING

OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will be a multi-site, randomized, two-arm, controlled clinical trial using OsteoGen® Plug (Test) vs Freeze-dried Bone Allograft with collagen barrier (Control) for alveolar ridge preservation (ARP) in posterior extraction sites with intact buccal cortical plates.

Official Title

OsteoGen® Plug vs Freeze-dried Bone Allograft With Collagen Barrier for Alveolar Ridge Preservation (ARP): A Randomized Controlled Trial

Quick Facts

Study Start:2024-03-28

Study Completion:2029-11-28

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06447844

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Subjects 18 to 75-yrs of age. * Subjects with a nonterminal premolar in need of extraction with intention to pursue implant replacement. * Proposed treatment site must have intact buccal cortical plates \> 1 mm in thickness (buccal bone dehiscence up to 25% root length is permissible). Apical lesions are acceptable which do not perforate the cortical plate). * Proposed treatment site must have intact adjacent natural teeth. (no adjacent edentulous sites or implants). * Subjects can provide self-care (oral hygiene) without disabilities requiring assistance with daily oral hygiene measures. * Subjects will have read, understood, and signed an institutional review board (IRB) approved Informed Consent Form (ICF). * Subjects must be able and willing to follow study procedures and instructions.	* Subjects with reported allergy or hypersensitivity to any of the products to be used in the study. * Subjects with untreated / active periodontal disease. * Subjects with vesiculobullous processes or other similar chronic oral lesions / conditions resulting in gingival irritation, discomfort/pain, or erosions. * Tobacco/Cannabis users including cigarettes, vape, cigars, or smokeless tobacco. * Uncontrolled medical conditions (e.g., diabetes mellitus, hypertension, cancer) * Subjects who are lactating or pregnant or planning to become pregnant through their projected study duration. * Subjects who would require a tissue supported interim prosthesis i.e. acrylic / valplast RPD (tooth supported interim prostheses i.e. essix retainers are acceptable) * Subjects with long-term history of oral bisphosphonates (\> 10 years). * Subjects with a history of intravenous bisphosphonates. * Subjects taking medications known to affect gingival conditions. (e.g., hyperplasia) * Subjects taking corticosteroids or immunosuppressants on a regular basis prior to baseline examination. * Subjects taking anticoagulant medications such as warfarin or Plavix or Eliquis who are not medically cleared to hold medication prior to and during procedure. * Subjects participating in other clinical studies involving therapeutic intervention (either medical or dental). * Subjects, who in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Inclusion Criteria

Exclusion Criteria

* Subjects 18 to 75-yrs of age.
* Subjects with a nonterminal premolar in need of extraction with intention to pursue implant replacement.
* Proposed treatment site must have intact buccal cortical plates \> 1 mm in thickness (buccal bone dehiscence up to 25% root length is permissible). Apical lesions are acceptable which do not perforate the cortical plate).
* Proposed treatment site must have intact adjacent natural teeth. (no adjacent edentulous sites or implants).
* Subjects can provide self-care (oral hygiene) without disabilities requiring assistance with daily oral hygiene measures.
* Subjects will have read, understood, and signed an institutional review board (IRB) approved Informed Consent Form (ICF).
* Subjects must be able and willing to follow study procedures and instructions.

* Subjects with reported allergy or hypersensitivity to any of the products to be used in the study.
* Subjects with untreated / active periodontal disease.
* Subjects with vesiculobullous processes or other similar chronic oral lesions / conditions resulting in gingival irritation, discomfort/pain, or erosions.
* Tobacco/Cannabis users including cigarettes, vape, cigars, or smokeless tobacco.
* Uncontrolled medical conditions (e.g., diabetes mellitus, hypertension, cancer)
* Subjects who are lactating or pregnant or planning to become pregnant through their projected study duration.
* Subjects who would require a tissue supported interim prosthesis i.e. acrylic / valplast RPD (tooth supported interim prostheses i.e. essix retainers are acceptable)
* Subjects with long-term history of oral bisphosphonates (\> 10 years).
* Subjects with a history of intravenous bisphosphonates.
* Subjects taking medications known to affect gingival conditions. (e.g., hyperplasia)
* Subjects taking corticosteroids or immunosuppressants on a regular basis prior to baseline examination.
* Subjects taking anticoagulant medications such as warfarin or Plavix or Eliquis who are not medically cleared to hold medication prior to and during procedure.
* Subjects participating in other clinical studies involving therapeutic intervention (either medical or dental).
* Subjects, who in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Contacts and Locations

Study Locations (Sites)

McClain and Schallhorn Periodontics and Implant Dentistry

Aurora, Colorado, 80012-3260

United States

Colorado Gum Care

Broomfield, Colorado, 80020

United States

The Perio Studio

Boston, Massachusetts, 02108

United States

Seven Lakes Periodontics

Fenton, Michigan, 48430

United States

Perio & Implant Associates of Middle TN

Nashville, Tennessee, 37215

United States

Perio Health Professionals

Houston, Texas, 77063-7229

United States

Gulf Coast Periodontics

Victoria, Texas, 77904

United States

WisNova Institute of Dental Specialists

Kenosha, Wisconsin, 53144-4292

United States

Collaborators and Investigators

Sponsor: McGuire Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-28

Study Completion Date2029-11-28

Study Record Updates

Study Start Date2024-03-28

Study Completion Date2029-11-28

Terms related to this study

Additional Relevant MeSH Terms

Nonterminal Premolar Needing Extraction